首页> 外国专利> Use of a controlled release dosage form comprising an opioid agonist and an antagonist opoide in a controlled release Matrix which contains at least a Hydrophobic PolymerAnd at least a Fatty alcohol or fatty acid to prevent the formation of an excerpt of This formulation.

Use of a controlled release dosage form comprising an opioid agonist and an antagonist opoide in a controlled release Matrix which contains at least a Hydrophobic PolymerAnd at least a Fatty alcohol or fatty acid to prevent the formation of an excerpt of This formulation.

机译:在包含至少一种疏水性聚合物和至少一种脂肪醇或脂肪酸的控释基质中包含阿片样物质激动剂和拮抗剂阿片的控释剂型的用途,以防止形成该制剂的摘录。

摘要

Controlled release dosage form comprising a controlled release Matrix of homogeneous comprising a Hydrophobic material.At least a Hydrophobic Polymer and at least one Fatty alcohol or Fatty Acid, an opioid agonist and an opioid antagonist.
机译:控释剂型包含均质的控释基质,所述均质包含疏水性材料。至少疏水性聚合物和至少一种脂肪醇或脂肪酸,阿片样物质激动剂和阿片样物质拮抗剂。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号